Skip to main content
. Author manuscript; available in PMC: 2016 Sep 6.
Published in final edited form as: Vet Comp Oncol. 2015 Jun 25;14(Suppl 1):136–146. doi: 10.1111/vco.12158

Table A1.

Modified UW Madison (25 week) protocol

Week
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 23 25
L-aspa x
Vincab x x x x x x x x
CTXc x x x x
DOXOd x x x x
Prede x x x x x x x x x x x x x x x x x x x x x x x x
a

L-asparaginase was given at the discretion of the clinician at a dose of 400 IU kg−1 SQ or 2500 IU cat−1 SQ.

b

Vincristine or vinblastine was given at the discretion of the prescribing clinician. Vincristine was given at 0.5–0.7mgm−2, IV or vinblastine was given at 1.5mgm−2, IV.

c

Cyclophosphamide (Cytoxan) was given 200–250mgm−2 IV or PO.

d

Doxorubicin was given at 1mg kg−1 or 25 mgm−2 IV.

e

Prednisone or prednisolone was given at 1–2mg kg−1 PO q24 h continued through the protocol to be tapered upon completion. Tapering occurred earlier at the discretion of the clinician.